Clause Library

Payment Terms

Payment Terms

Sample Clauses

Details the conditions under which payments are to be made, including amounts, deadlines, and penalties for late payment.

Details the conditions under which payments are to be made, including amounts, deadlines, and penalties for late payment.

Drafting Tips

Define payment amounts, schedules, late fees, and interest on overdue payments. Clarify acceptable payment methods and conditions for final payments.

Sample Clauses

Source License Agreement [BIOPHYTIS SA]
(2021-01-19) - I0 - Pharmaceutical Preparations

All payments are made in euro, plus VAT at the rate applicable on the invoice date, by bank transfer within thirty (30) days from the date of the invoice issued by IDF Innov, in the name of: Biophytis Accounting Sorbonne Université BC9 4 place Jussieu 75252 Paris Cedex 5, France. Transfers shall be made to the bank details indicated on the invoices. Any late payment of the sums due hereunder shall give rise to the application by IDF Innov of a penalty equal to three (3) times the legal interest rate, payable from the day after the due date of the receivable. In addition to the late payment compensation, BIOPHYTIS shall be liable for a fixed-rate compensation of [****] euro towards the recovery costs of any amount not paid on its due date.
Source Property Lease/Pre-lease Contract [111, INC.]
(2018-08-15) - E9 - Retail-Drug Stores and Proprietary Stores

All rents and Performance Bond hereunder shall be paid to the bank account of Party B. i. Payee: Shanghai Zhangjiang Hi-tech Park Development Co., Ltd. ii. Bank: China Construction Bank, Shanghai Zhangjiang Sub-branch iii. Account number: [Account.Number]
Source Amended and Restated Commercial Agreement [ALIBABA GROUP HOLDING LTD]
(2018-02-02) - K3 - Services-Business Services, NEC

Within thirty (30) days following the end of each Calendar Quarter during the Term, Provider shall deliver to each Recipient Party (with a copy to Recipient) (i) an invoice for the Payment Processing Fee payable by such Recipient Party for such Calendar Quarter, and (ii) true and complete statements of the Base TPV actually processed by Provider as part of the Services provided to such Recipient Party during the applicable Calendar Quarter, including a detailed explanation of how such Base TPV and the applicable Payment Processing Fee were calculated (each such invoice and associated statements, an 'Invoice'). Subject to Section 7.2(b), each Recipient Party shall pay, and Recipient shall cause each Recipient Party to pay, all undisputed amounts due pursuant to each Invoice within thirty (30) days after the applicable Recipient Party's receipt thereof.
Source Product License Agreement [APTEVO THERAPEUTICS INC.]
(2016-06-29) - DE - Pharmaceutical Preparations

2.9 Invoices. All amounts invoiced under this Agreement shall be payable within forty-five (45) days of the invoice recipient's receipt of such invoice.
Source Transition Services Agreement [ARCOSA, INC.]
(2018-08-01) - DE - Fabricated Structural Metal Products

(a) Each month, the Service Provider shall deliver a statement to the Service Recipient for Services provided to the Service Recipients during the preceding month, and each such statement shall set forth a brief description of each such Service and the amounts charged for such Service based on the consideration set forth in the applicable Schedule, the Rental Costs (as defined in Section 2.06(b)) or otherwise agreed by the Parties in writing (the 'Fee'), as well as any Taxes, duties, imposts, charges, fees or other levies due and owing in accordance with Section 2.03 hereof, and the aggregate of such amounts shall be due and payable by the Service Recipient within thirty (30) days after the date of receipt of such statement.
Source Registration Statement (S-1) [4D MOLECULAR THERAPEUTICS, INC.]
(2020-11-17) - DE - Biological Products, (No Diagnostic Substances)

Pursuant to the uniQure Agreement, the Company received upfront payments of $0.2 million, and was entitled to receive (i) contingent payments for the achievement of research and development milestones of up to $5.0 million for each licensed product selected under the arrangement, and (ii) royalties in the single digit range on future sales of the potential product candidates and sublicense consideration in the low teens to low thirties range on any future sublicensing arrangements. The Company also received capped research and development service fees based on contractual full-time employee rates per year. In connection with the performance obligations under the uniQure Agreement, the founders of 4D Molecular Therapeutics, LLC received equity options to purchase an aggregate of 609,744 of uniQure ordinary shares that vest over the initial three-year term of the agreement.
Source Land Lease Agreement [ALCOA UPSTREAM CORP]
(2016-08-12) - DE - Primary Production of Aluminum

All payments of Rent shall be due and payable within thirty (30) days after Lessee's receipt of Lessor's invoice. All payments of Rent shall be made without offset, deduction, credit, abatement, reduction or counterclaim of any kind, in lawful money of the United States of America. Lessee shall not have the right to deposit any disputed Rent in court or pursuant to any court-ordered escrow or with any court-appointed receiver, master or trustee. All payments of Rent shall be made at Lessor's address or precedent to wire transfer instructions as Lessor shall designate by notice to Lessee from time to time.
Source Amended and Restated Commercial Agreement [ALIBABA GROUP HOLDING LTD]
(2018-02-02) - K3 - Services-Business Services, NEC

Within thirty (30) days following the end of each Calendar Quarter during the Term, Provider shall deliver to each Recipient Party (with a copy to Recipient) (i) an invoice for the Payment Processing Fee payable by such Recipient Party for such Calendar Quarter, and (ii) true and complete statements of the Base TPV actually processed by Provider as part of the Services provided to such Recipient Party during the applicable Calendar Quarter, including a detailed explanation of how such Base TPV and the applicable Payment Processing Fee were calculated (each such invoice and associated statements, an 'Invoice'). Subject to Section 7.2(b), each Recipient Party shall pay, and Recipient shall cause each Recipient Party to pay, all undisputed amounts due pursuant to each Invoice within thirty (30) days after the applicable Recipient Party's receipt thereof.
Source Term Loan Credit Agreement [ALLEGRO MICROSYSTEMS, INC.]
(2020-10-13) - Semiconductors & Related Devices

The prices of the Products and the terms of payment shall be as set forth on Exhibit A to this Agreement.
Source Exclusive License Agreement [ALNYLAM PHARMACEUTICALS, INC.]
(2018-05-04) - Pharmaceutical Preparations

Except as expressly provided herein, all payments by one Party to the other Party under this Agreement shall be non-refundable and non-creditable and not subject to set-off. Royalties shown to have accrued by each royalty report shall be due and payable [Payment.DueDate] days following the date such royalty report is due. In addition, Alnylam shall prepare and deliver to Genzyme any additional reports for sales of the Licensed Products as required under any applicable Genzyme In-Licenses.
Source Master Service Agreement [APTORUM GROUP LTD]
(2019-07-02) - E9 - Pharmaceutical Preparations

Unless otherwise specified in applicable Work Order, Client shall provide payment to Company within thirty (30) days after the date of receipt of Company's invoice for completed Services under the Work Order. Payments by Client shall be made by wire funds transfer into the bank account appointed by Company in accordance with the payment instruction provided in each invoice.
Source Primary Supplier Distribution Agreement [ARKO CORP.]
(2020-10-29) - DE - Retail-Convenience Stores

Supplier by Customer for such Order (the "Invoice"). Customer shall pay for the Products and Custom Products actually delivered by ACH [***]. Supplier reserves the right to alter or restrict the above terms of payment or to require payment prior to the scheduled delivery time if, in Supplier's sole discretion, Customer's financial condition has materially deteriorated or other circumstances do not reasonably warrant delivery on the terms originally specified in the Delivery Schedule, "Exhibit C." Supplier agrees that any changes in terms will not be made unreasonably. Supplier shall give Customer reasonable notice before such changes to any payment or delivery terms are made due to the foregoing reasons.
Source Material Change Report [AURORA CANNABIS INC]
(2018-10-05) - A1 - Medicinal Chemicals & Botanical Products

Any fees or compensation payable to the Trustee shall be paid by the Corporation within 30 days of issuance of an invoice therefor and, if not so paid, shall bear interest at a rate per annum to the then-current rate of interest charged by the Trustee to its corporate clients.
Source Deed of Assignment (Public-Private Partnership) [BIOCRUDE TECHNOLOGIES USA, INC.]
(2017-05-26) - NV - Refuse Systems

Upon presentation of Invoice and offset from Revolving Letter of Credit (RLC); amount of escrowed RLC is for 12 months of future payment.
Source Manufacturing and Supply Agreement [BIONANOMATRIX INC]
(2018-05-14) - DE - Laboratory Analytical Instruments

5.4 Payment Terms. Customer will be invoiced monthly based upon Activities allocated as described in Section 2.1. The invoice will be for at least the minimum number of Moves equal to the monthly Activity Allocation. If the actual Moves for the preceding month are more than the Activity Allocation, the total Moves will be invoiced. Each SVTC invoice hereunder shall be accompanied by a detailed report containing Activity Allocation, actual Moves, quantity of Moves invoiced and other payment due and payable. Payment obligations under this Schedule shall survive any termination or expiration of this Schedule.
Source Manufacturing and Supply Agreement [BIONANOMATRIX INC]
(2018-05-14) - DE - Laboratory Analytical Instruments

(a) Customer will be invoiced monthly for all services and deliverables provided by SVTC during the previous month. All other payments required hereunder shall be invoiced on a monthly basis at the beginning of each calendar month and shall be paid within […***…]. Each SVTC invoice hereunder shall be accompanied by a detailed report containing supporting information, as Customer may reasonably request, used to determine the amounts due hereunder. (b) Except as may be agreed otherwise in writing, all payments due to SVTC under this Agreement shall be made by bank wire transfer to a designated bank account. All payments shall be made in U.S. dollars unless otherwise agreed by the parties. If any payments are more than […***…] late, Customer will pay SVTC, in addition to any other remedies that may be available to SVTC, a late payment of the lower of […***…] per month or the highest rate allowed by law for all past due amounts until paid.
Source Securities Registration Form [BROADSTONE NET LEASE, INC.]
(2017-06-29) - Real Estate Investment Trusts

Borrowings under each of the Term Note 1, Term Note 2, Term Note 3, and the Revolver are payable interest only, monthly, with the principal amount due in full at maturity.
Source Sponsored Research Agreement [CABALETTA BIO, INC.]
(2019-09-06) - DE - Biological Products, (No Diagnostic Substances)

All payments are to be payable in United States dollars, and if by check, made out to "The Trustees of the University of Pennsylvania", and sent to: [Payment.Address] (Wire transfers preferred for sponsored research agreements) - For all payments made by wire transfer, banking information is as follows: Bank Name: [Bank.Name] Bank Address: [Bank.Address] ACH Coordinator: [ACH.Coordinator] Account Title: [Account.Title] Account Type: [Account.Type] Account #: [Account.Number] ABA Routing #: [ABA.Routing.Number] SWIFT CODE: [SWIFT.CODE] CHIPS: [CHIPS] Reference: [Reference]
Source Amendment to Collaborative Research and License Agreement [C4 THERAPEUTICS, INC.]
(2021-03-11) - DE - Biological Products, (No Diagnostic Substances)

Under the Calico License Agreement, Calico paid an upfront amount of $5.0 million and certain annual payments totaling $5.0 million through December 31, 2020 and pays target initiation fees and reimburses the Company for a number of FTEs, depending on the stage of the research, at specified market rates
Source Amendment to Collaborative Research and License Agreement [C4 THERAPEUTICS, INC.]
(2021-03-11) - DE - Biological Products, (No Diagnostic Substances)

The nonrefundable upfront and certain annual payments are not creditable against any other payments. Calico will reimburse the Company for a contractually defined number of FTEs per target depending on the phase of development, unless otherwise agreed upon by the CJRC. The research will be performed by the Company over the research term in accordance with the research plan. For the year ended December 31, 2019 the Company received $2.0 million in cash consideration for milestone revenue and no additional consideration in the form of cash received for target initiation fees. The Company recorded an accounts receivable of $1.0 million for additional target initiation fees in 2019 and received payment in 2020.
Source Master Repurchase Agreement [CALIBER HOME LOANS, INC.]
(2020-10-07) - DE - Finance Services

Except to the extent otherwise provided herein, all payments of Repurchase Price, including Price Differential, and other amounts to be paid by the Seller under this Repurchase Agreement, shall be made in Dollars, in immediately available funds, without deduction, set-off or counterclaim, to the Buyer, at the following account maintained by the Buyer: Account No. [***], Citibank, N.A.